問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
National Taiwan University Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
Division of Others
下載
2025-10-01 - 2030-12-31
Condition/Disease
Diffuse Large B-Cell Lymphoma、 Chronic Lymphocytic Leukemia 、B Cell Malignancies 、Non-Hodgkin's Lymphoma
Test Drug
lozenges
Participate Sites3Sites
Recruiting3Sites
2025-04-01 - 2029-11-30
Participate Sites2Sites
Recruiting2Sites
2016-12-13 - 2022-05-05
Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)
Venetoclax (ABT-199, GDC-0199)
Participate Sites4Sites
Terminated3Sites
Division of Hematology & Oncology
2019-01-01 - 2026-06-30
Participate Sites9Sites
Recruiting9Sites
2023-02-01 - 2027-12-31
Relapsed or Refractory Peripheral T-cell Lymphoma
Kepida
Participate Sites7Sites
Not yet recruiting4Sites
2021-11-01 - 2029-08-30
2021-11-01 - 2029-03-30
2021-07-01 - 2024-12-31
Participate Sites1Sites
Recruiting1Sites
2014-01-01 - 2018-12-31
Terminated4Sites
2024-12-01 - 2024-12-02
全部
